Hematologic toxicity assessment in solid tumor patients treated with cetuximab: A pooled analysis of 18 randomized controlled trials.

Cui, Ran; Chu, Li; Liu, Zhu-Qing; Xiao, Yuan-Yuan; Zhu, Xiao-Li; Chen, Yi-Jing; Xu, Qing

Cui, Ran; Chu, Li; Liu, Zhu-Qing; Xiao, Yuan-Yuan; Zhu, Xiao-Li; Chen, Yi-Jing; Xu, Qing.

Afiliação

Cui R; Department of Oncology, Shanghai Tenth People's Hospital, Tongji University, School of Medicine, Zhabei District, Shanghai, 200072, China.
Chu L; Department of Oncology, Shanghai Tenth People's Hospital, Tongji University, School of Medicine, Zhabei District, Shanghai, 200072, China.
Liu ZQ; Department of Oncology, Shanghai Tenth People's Hospital, Tongji University, School of Medicine, Zhabei District, Shanghai, 200072, China.
Xiao YY; Department of Oncology, Shanghai Tenth People's Hospital, Tongji University, School of Medicine, Zhabei District, Shanghai, 200072, China.
Zhu XL; State Key Laboratory of Genetic Engineering, Institute of Genetics, School of Life Science, Fudan University, Shanghai, 200433, China.
Chen YJ; Department of Oncology, Shanghai Tenth People's Hospital, Tongji University, School of Medicine, Zhabei District, Shanghai, 200072, China.
Xu Q; Department of Oncology, Shanghai Tenth People's Hospital, Tongji University, School of Medicine, Zhabei District, Shanghai, 200072, China.

Int J Cancer ; 138(11): 2771-3, 2016 Jun 01.

Article em En | MEDLINE | ID: mdl-26789526

Assuntos

Anticorpos Monoclonais Humanizados/efeitos adversos; Antineoplásicos/efeitos adversos; Neoplasias/tratamento farmacológico; Neutropenia/induzido quimicamente; Humanos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Anticorpos Monoclonais Humanizados / Neoplasias / Neutropenia / Antineoplásicos Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google